MufaddalAdil Alaithan YOU? Author Swipe

Last 10y

Outcome of rituximab therapy in patients with systemic lupus erythematosus Open

Hanan Al Rayes, MufaddalAdil Alaithan, Hussein Halabi, MaryamMohammed Shamaa, RawanNaser Alharbi , et al. · 2023

Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease affecting multiple organs. Rituximab (RTX) is an anti-CD20 monoclonal antibody that is an approved treatment for various autoimmune diseases. However, no randomize…